Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$401M |
| 2 |
NVIDIA
NVDA
|
$333M |
| 3 |
Costco
COST
|
$236M |
| 4 |
Amazon
AMZN
|
$215M |
| 5 |
Johnson & Johnson
JNJ
|
$160M |
Top Sells
| 1 |
Broadcom
AVGO
|
$322M |
| 2 |
Super Micro Computer
SMCI
|
$284M |
| 3 |
JPMorgan Chase
JPM
|
$178M |
| 4 |
WIRE
Encore Wire Corp
WIRE
|
$160M |
| 5 |
Intel
INTC
|
$152M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.49% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Corvus Pharmaceuticals
CRVS
$435M
| $63K | ﹤0.01% |
11,924
| – | – |
|
3277
Aterian
ATER
$9.68M
| $62.7K | ﹤0.01% |
+21,778
| New | +$62.7K |
|
3278
ReWalk Robotics
LFWD
$8.68M
| $62K | ﹤0.01% |
19,007
+5,459
| +40% | +$17.8K |
|
|
AFMD
3279
DELISTED
Affimed
AFMD
| $60.9K | ﹤0.01% |
+18,120
| New | +$60.9K |
|
3280
Stabilis Solutions
SLNG
$72.2M
| $60.6K | ﹤0.01% |
12,779
+2,166
| +20% | +$10.3K |
|
|
ME
3281
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $60.5K | ﹤0.01% |
8,705
| – | – |
|
3282
Prelude Therapeutics
PRLD
$67.9M
| $60.3K | ﹤0.01% |
29,082
+8
| +0% | +$17 |
|
|
RDNW
3283
RideNow Group, Inc. Class B Common Stock
RDNW
$135M
| $60K | ﹤0.01% |
12,533
-16,649
| -57% | -$79.7K |
|
3284
Milestone Pharmaceuticals
MIST
$152M
| $60K | ﹤0.01% |
39,450
| – | – |
|
|
ALLK
3285
DELISTED
Allakos
ALLK
| $58.8K | ﹤0.01% |
89,998
-36,644
| -29% | -$23.9K |
|
3286
Sono-Tek
SOTK
$55.4M
| $58.6K | ﹤0.01% |
14,529
-1,663
| -10% | -$6.7K |
|
3287
Marker Therapeutics
MRKR
$11.4M
| $57.2K | ﹤0.01% |
20,278
| – | – |
|
3288
Century Therapeutics
IPSC
$40.6M
| $56.9K | ﹤0.01% |
33,449
-41,866
| -56% | -$71.2K |
|
|
KLRS
3289
Kalaris Therapeutics, Inc. Common Stock
KLRS
$81.2M
| $56.3K | ﹤0.01% |
3,033
| – | – |
|
3290
Precigen
PGEN
$1.36B
| $54.1K | ﹤0.01% |
57,082
-1,673
| -3% | -$1.58K |
|
3291
iBio
IBIO
$16.2M
| $53.4K | ﹤0.01% |
+24,071
| New | +$53.4K |
|
3292
One Stop Systems
OSS
$127M
| $53.2K | ﹤0.01% |
22,257
| – | – |
|
3293
PharmaCyte Biotech
PMCB
$6.45M
| $52.7K | ﹤0.01% |
27,601
+2,005
| +8% | +$3.83K |
|
|
IAUX
3294
i-80 Gold Corp
IAUX
$652M
| $52K | ﹤0.01% |
44,847
+300
| +0.7% | +$348 |
|
3295
Lisata Therapeutics
LSTA
$19M
| $52K | ﹤0.01% |
17,340
+4
| +0% | +$12 |
|
3296
OPAL Fuels
OPAL
$65.5M
| $51.6K | ﹤0.01% |
14,126
| – | – |
|
3297
AYTU BioPharma
AYTU
$21.5M
| $51.3K | ﹤0.01% |
21,832
-1,719
| -7% | -$4.04K |
|
|
LEV
3298
DELISTED
The Lion Electric Company
LEV
| $51.3K | ﹤0.01% |
75,530
+300
| +0.4% | +$204 |
|
3299
BuzzFeed
BZFD
$68.9M
| $50.8K | ﹤0.01% |
19,068
+4
| +0% | +$11 |
|
3300
Edesa Biotech
EDSA
$17.2M
| $50.4K | ﹤0.01% |
11,333
| – | – |
|